HomeComparePRPIX vs JNJ

PRPIX vs JNJ: Dividend Comparison 2026

PRPIX yields 4.72% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRPIX wins by $7.2K in total portfolio value
10 years
PRPIX
PRPIX
● Live price
4.72%
Share price
$8.01
Annual div
$0.38
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$638.79
Full PRPIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PRPIX vs JNJ

📍 PRPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRPIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRPIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRPIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRPIX
Annual income on $10K today (after 15% tax)
$401.31/yr
After 10yr DRIP, annual income (after tax)
$542.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $160.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRPIX + JNJ for your $10,000?

PRPIX: 50%JNJ: 50%
100% JNJ50/50100% PRPIX
Portfolio after 10yr
$23.6K
Annual income
$733.29/yr
Blended yield
3.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRPIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRPIX buys
0
JNJ buys
0
No recent congressional trades found for PRPIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRPIXJNJ
Forward yield4.72%3.36%
Annual dividend / share$0.38$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.3K$20.0K
Annual income after 10y$638.79$827.78
Total dividends collected$5.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRPIX vs JNJ ($10,000, DRIP)

YearPRPIX PortfolioPRPIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,172$472.13$10,676$355.77+$496.00PRPIX
2$12,447$492.97$11,407$389.39+$1.0KPRPIX
3$13,832$513.30$12,198$426.53+$1.6KPRPIX
4$15,333$533.08$13,056$467.62+$2.3KPRPIX
5$16,959$552.28$13,987$513.12+$3.0KPRPIX
6$18,717$570.87$14,998$563.56+$3.7KPRPIX
7$20,616$588.83$16,098$619.52+$4.5KPRPIX
8$22,665$606.14$17,295$681.69+$5.4KPRPIX
9$24,874$622.80$18,599$750.82+$6.3KPRPIX
10$27,254$638.79$20,022$827.78+$7.2KPRPIX

PRPIX vs JNJ: Complete Analysis 2026

PRPIXStock

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in corporate debt securities. Holdings will mainly consist of investment-grade bonds, although the fund has the flexibility to purchase some below investment-grade bonds (also called high-yield bonds or junk bonds). It may invest in other securities in an effort to enhance income and achieve capital growth.

Full PRPIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PRPIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRPIX vs SCHDPRPIX vs JEPIPRPIX vs OPRPIX vs KOPRPIX vs MAINPRPIX vs ABBVPRPIX vs MRKPRPIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.